BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 15157827)

  • 1. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
    Philpott DJ; Viala J
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
    Peyrin-Biroulet L; Chamaillard M
    J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune sensing of microbes by Nod proteins.
    Kufer TA; Banks DJ; Philpott DJ
    Ann N Y Acad Sci; 2006 Aug; 1072():19-27. PubMed ID: 17057187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD15/NOD2 mutations in Crohn's disease.
    Hugot JP
    Ann N Y Acad Sci; 2006 Aug; 1072():9-18. PubMed ID: 17057186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
    Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility and regulation of inflammation in Crohn's disease. Relationship with the innate immune system.
    Peña AS; Peñate M
    Rev Esp Enferm Dig; 2002 Jun; 94(6):351-60. PubMed ID: 12432592
    [No Abstract]   [Full Text] [Related]  

  • 9. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
    Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
    Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
    Ogura Y; Bonen DK; Inohara N; Nicolae DL; Chen FF; Ramos R; Britton H; Moran T; Karaliuskas R; Duerr RH; Achkar JP; Brant SR; Bayless TM; Kirschner BS; Hanauer SB; Nuñez G; Cho JH
    Nature; 2001 May; 411(6837):603-6. PubMed ID: 11385577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant role of genetics in IBD: the NOD2 gene.
    Cho JH
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S18-22. PubMed ID: 12684585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini-review: the role of peptidoglycan recognition in innate immunity.
    Girardin SE; Philpott DJ
    Eur J Immunol; 2004 Jul; 34(7):1777-82. PubMed ID: 15214025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of Crohn's disease in the 21st century.
    Hume G; Radford-Smith GL
    Pathology; 2002 Dec; 34(6):561-7. PubMed ID: 12555995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
    Devlin SM; Yang H; Ippoliti A; Taylor KD; Landers CJ; Su X; Abreu MT; Papadakis KA; Vasiliauskas EA; Melmed GY; Fleshner PR; Mei L; Rotter JI; Targan SR
    Gastroenterology; 2007 Feb; 132(2):576-86. PubMed ID: 17258734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.
    Watanabe T; Kitani A; Murray PJ; Strober W
    Nat Immunol; 2004 Aug; 5(8):800-8. PubMed ID: 15220916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease: Crohn's disease and the success of NODern genetics.
    Newman B; Siminovitch K
    Clin Invest Med; 2003 Dec; 26(6):303-14. PubMed ID: 14690304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From gene to disease; 'frame shift'-mutation in the CARD15-gene and Crohn's disease].
    van der Linde K; Kuipers EJ; de Rooij FW; Wilson JH
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2539-42. PubMed ID: 12532667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein Nod2: an innate receptor more complex than previously assumed.
    Lecat A; Piette J; Legrand-Poels S
    Biochem Pharmacol; 2010 Dec; 80(12):2021-31. PubMed ID: 20643110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of Crohn's disease.
    Russell RK; Nimmo ER; Satsangi J
    Curr Opin Genet Dev; 2004 Jun; 14(3):264-70. PubMed ID: 15172669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease is caused by mutations in the bacterial response protein NOD2.
    Press RD
    Mol Diagn; 2001 Dec; 6(4):347-8. PubMed ID: 11837220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.